WSO December 2023 – Issue 3 - 1245

Cappellari et al.
1245
in five patients develop HT or early CED, but rate of symptomatic
HT and/or CED is very low. However, even if
asymptomatic at 24 h, PH could delay the introduction of
secondary prevention antithrombotic therapy and expose
the patients to a higher risk of early stroke recurrence, while
CED could increase its extension and cause a neurological
deterioration beyond 24 h. Intra- and post-operative management
during anesthesia should assume an increasingly
relevant and specialized role, both to gain new insights into
the complex mechanisms underlying reperfusion injury and
to modify the modifiable risk factors associated with HT
and early CED, such as
maintaining good collateral
circulation.
Conclusion
Our study reported that higher NIHSS, lower ASPECTS,
and longer onset-to-groin time were predictors for both HT
and early CED in stroke patients after first-pass complete
recanalization during MT. General anesthesia and good
collaterals were inversely associated with HT and CED,
respectively. Longer procedure time was predictor of early
CED.
Acknowledgements
We thank all persons who participated in IRETAS.
Author contributions
Manuel Cappellari: design and conceptualization of the study,
acquisition of data, analysis and interpretation of the data, and
drafting the manuscript for intellectual content. All authors: acquisition
of data and revising the manuscript for intellectual content.
Declaration of conflicting interests
The author(s) declared the following potential conflicts of interest
with respect to the research, authorship, and/or publication of this
article: Manuel Cappellari received consultancy or advisory board
fees or speaker's honoraria from Boehringer Ingelheim, Pfizer/
Bristol Meyer Squibb, and Daiichi Sankyo. Andrea Zini received
consulting fees from Boehringer-Ingelheim consulting fees from
Boehringer-Ingelheim, Alexion and CLS Behring. All other
authors report no conflicts of interest. The other authors report no
conflicts.
Funding
The author(s) disclosed receipt of the following financial support
for the research, authorship, and/or publication of this article:
" The project
''Registro Nazionale Trattamento Ictus Acuto''
(RFPS-2006-1-336562) was funded by grants from the Italian
Ministry of Health within the framework of 2006 Finalized
Research Programmes (D.Lgs.n.502/1992). The present study
received no funding.
ORCID iDs
Manuel Cappellari
https://orcid.org/0000-0002-3534-3201
Ilaria Casetta
Andrea Zini
Marta Iacobucci
Ettore Nicolini
Francesco Capasso
Guido Bigliardi
https://orcid.org/0000-0003-4099-8875
https://orcid.org/0000-0003-1087-6092
https://orcid.org/0000-0001-5312-7206
https://orcid.org/0000-0003-1486-4507
https://orcid.org/0000-0002-3911-3278
https://orcid.org/0000-0002-8481-6327
Supplemental material
Supplemental material for this article is available online.
References
1. Turc G, Bhogal P, Fischer U, et al. European Stroke
Organisation (ESO)-European Society for Minimally
Invasive Neurological Therapy (ESMINT) guidelines on
mechanical thrombectomy in acute ischemic stroke. J
Neurointervent Surg 2019; 11: 535-538.
2. Kleine JF, Wunderlich S, Zimmer C and Kaesmacher J. Time
to redefine success? TICI 3 versus TICI 2b recanalization in
middle cerebral artery occlusion treated with thrombectomy. J
Neurointerv Surg 2017; 9: 117-121.
3. Bai X, Zhang X, Yang W, et al. Influence of first-pass effect on
recanalization outcomes in the era of mechanical thrombectomy:
a systemic review and meta-analysis. Neuroradiology
2021; 63: 795-807.
4. Nikoubashman O, Dekeyzer S, Riabikin A, et al. True firstpass
effect. Stroke 2019; 50: 2140-2146.
5. Di Maria F, Kyheng M, Consoli A, et al. Identifying the predictors
of first-pass effect and its influence on clinical outcome
in the setting of endovascular thrombectomy for acute
ischemic stroke: results from a multicentric prospective registry.
Int J Stroke 2021; 16: 20-28.
6. Ben Hassen W, Tordjman M, Boulouis G, et al. Benefit of
firstpass complete reperfusion in thrombectomy is mediated
by limited infarct growth. Eur J Neurol 2021; 28: 124-131.
7. Maier IL, Almallouhi E, Psychogios MN, et al. Importance
of first pass reperfusion in endovascular stroke care-insights
from thrombectomy and aneurysm registry (STAR). Stroke
2022; 2: e000427.
8. Pan J, Konstas AA, Bateman B, Ortolano GA and PileSpellman
J. Reperfusion injury following cerebral ischemia:
pathophysiology, MR imaging, and potential therapies.
Neuroradiology 2007; 49: 93-102.
9. Hong JM, Kim DS and Kim M. Transformation after ischemic
stroke: mechanisms and management. Front Neurol 2021; 12:
703258.
10. Hofmeijer J, Algra A, Kappelle LJ and Van der Worp HB.
Predictors of life-threatening brain edema in middle cerebral
artery infarction. Cerebrovasc Dis 2008; 25: 176-184.
11. Bai J and Lyden PD. Revisiting cerebral postischemic reperfusion
injury: new insights in understanding reperfusion failure,
hemorrhage, and edema. Int J Stroke 2015; 10: 143-152.
12. Thorén M, Dixit A, Escudero-Martínez I, et al. Effect of recanalization
on cerebral edema in ischemic stroke treated with
thrombolysis and/or endovascular therapy. Stroke 2020; 51:
216-223.
13. Cheripelli BK, Huang X, MacIsaac R and Muir KW.
Interaction of recanalization, intracerebral hemorrhage, and
International Journal of Stroke, 18(10)
https://www.orcid.org/0000-0003-4099-8875 https://www.orcid.org/0000-0003-1087-6092 https://www.orcid.org/0000-0001-5312-7206 https://www.orcid.org/0000-0003-1486-4507 https://www.orcid.org/0000-0002-3911-3278 https://www.orcid.org/0000-0002-8481-6327 https://www.orcid.org/0000-0002-3534-3201

WSO December 2023 – Issue 3

Table of Contents for the Digital Edition of WSO December 2023 – Issue 3

Contents
WSO December 2023 – Issue 3 - Cover1
WSO December 2023 – Issue 3 - Cover2
WSO December 2023 – Issue 3 - 1143
WSO December 2023 – Issue 3 - Contents
WSO December 2023 – Issue 3 - 1145
WSO December 2023 – Issue 3 - 1146
WSO December 2023 – Issue 3 - 1147
WSO December 2023 – Issue 3 - 1148
WSO December 2023 – Issue 3 - 1149
WSO December 2023 – Issue 3 - 1150
WSO December 2023 – Issue 3 - 1151
WSO December 2023 – Issue 3 - 1152
WSO December 2023 – Issue 3 - 1153
WSO December 2023 – Issue 3 - 1154
WSO December 2023 – Issue 3 - 1155
WSO December 2023 – Issue 3 - 1156
WSO December 2023 – Issue 3 - 1157
WSO December 2023 – Issue 3 - 1158
WSO December 2023 – Issue 3 - 1159
WSO December 2023 – Issue 3 - 1160
WSO December 2023 – Issue 3 - 1161
WSO December 2023 – Issue 3 - 1162
WSO December 2023 – Issue 3 - 1163
WSO December 2023 – Issue 3 - 1164
WSO December 2023 – Issue 3 - 1165
WSO December 2023 – Issue 3 - 1166
WSO December 2023 – Issue 3 - 1167
WSO December 2023 – Issue 3 - 1168
WSO December 2023 – Issue 3 - 1169
WSO December 2023 – Issue 3 - 1170
WSO December 2023 – Issue 3 - 1171
WSO December 2023 – Issue 3 - 1172
WSO December 2023 – Issue 3 - 1173
WSO December 2023 – Issue 3 - 1174
WSO December 2023 – Issue 3 - 1175
WSO December 2023 – Issue 3 - 1176
WSO December 2023 – Issue 3 - 1177
WSO December 2023 – Issue 3 - 1178
WSO December 2023 – Issue 3 - 1179
WSO December 2023 – Issue 3 - 1180
WSO December 2023 – Issue 3 - 1181
WSO December 2023 – Issue 3 - 1182
WSO December 2023 – Issue 3 - 1183
WSO December 2023 – Issue 3 - 1184
WSO December 2023 – Issue 3 - 1185
WSO December 2023 – Issue 3 - 1186
WSO December 2023 – Issue 3 - 1187
WSO December 2023 – Issue 3 - 1188
WSO December 2023 – Issue 3 - 1189
WSO December 2023 – Issue 3 - 1190
WSO December 2023 – Issue 3 - 1191
WSO December 2023 – Issue 3 - 1192
WSO December 2023 – Issue 3 - 1193
WSO December 2023 – Issue 3 - 1194
WSO December 2023 – Issue 3 - 1195
WSO December 2023 – Issue 3 - 1196
WSO December 2023 – Issue 3 - 1197
WSO December 2023 – Issue 3 - 1198
WSO December 2023 – Issue 3 - 1199
WSO December 2023 – Issue 3 - 1200
WSO December 2023 – Issue 3 - 1201
WSO December 2023 – Issue 3 - 1202
WSO December 2023 – Issue 3 - 1203
WSO December 2023 – Issue 3 - 1204
WSO December 2023 – Issue 3 - 1205
WSO December 2023 – Issue 3 - 1206
WSO December 2023 – Issue 3 - 1207
WSO December 2023 – Issue 3 - 1208
WSO December 2023 – Issue 3 - 1209
WSO December 2023 – Issue 3 - 1210
WSO December 2023 – Issue 3 - 1211
WSO December 2023 – Issue 3 - 1212
WSO December 2023 – Issue 3 - 1213
WSO December 2023 – Issue 3 - 1214
WSO December 2023 – Issue 3 - 1215
WSO December 2023 – Issue 3 - 1216
WSO December 2023 – Issue 3 - 1217
WSO December 2023 – Issue 3 - 1218
WSO December 2023 – Issue 3 - 1219
WSO December 2023 – Issue 3 - 1220
WSO December 2023 – Issue 3 - 1221
WSO December 2023 – Issue 3 - 1222
WSO December 2023 – Issue 3 - 1223
WSO December 2023 – Issue 3 - 1224
WSO December 2023 – Issue 3 - 1225
WSO December 2023 – Issue 3 - 1226
WSO December 2023 – Issue 3 - 1227
WSO December 2023 – Issue 3 - 1228
WSO December 2023 – Issue 3 - 1229
WSO December 2023 – Issue 3 - 1230
WSO December 2023 – Issue 3 - 1231
WSO December 2023 – Issue 3 - 1232
WSO December 2023 – Issue 3 - 1233
WSO December 2023 – Issue 3 - 1234
WSO December 2023 – Issue 3 - 1235
WSO December 2023 – Issue 3 - 1236
WSO December 2023 – Issue 3 - 1237
WSO December 2023 – Issue 3 - 1238
WSO December 2023 – Issue 3 - 1239
WSO December 2023 – Issue 3 - 1240
WSO December 2023 – Issue 3 - 1241
WSO December 2023 – Issue 3 - 1242
WSO December 2023 – Issue 3 - 1243
WSO December 2023 – Issue 3 - 1244
WSO December 2023 – Issue 3 - 1245
WSO December 2023 – Issue 3 - 1246
WSO December 2023 – Issue 3 - 1247
WSO December 2023 – Issue 3 - 1248
WSO December 2023 – Issue 3 - 1249
WSO December 2023 – Issue 3 - 1250
WSO December 2023 – Issue 3 - 1251
WSO December 2023 – Issue 3 - 1252
WSO December 2023 – Issue 3 - 1253
WSO December 2023 – Issue 3 - 1254
WSO December 2023 – Issue 3 - 1255
WSO December 2023 – Issue 3 - 1256
WSO December 2023 – Issue 3 - 1257
WSO December 2023 – Issue 3 - 1258
WSO December 2023 – Issue 3 - 1259
WSO December 2023 – Issue 3 - 1260
WSO December 2023 – Issue 3 - Cover3
WSO December 2023 – Issue 3 - Cover4
https://europe.nxtbook.com/nxteu/sageuk/wso_202404
https://europe.nxtbook.com/nxteu/sageuk/ukstrokeforum_202402_supp
https://europe.nxtbook.com/nxteu/sageuk/wso_202403
https://europe.nxtbook.com/nxteu/sageuk/wso_202402
https://europe.nxtbook.com/nxteu/sageuk/wso_202401
https://europe.nxtbook.com/nxteu/sageuk/wso_2023123_US_UKOnly
https://europe.nxtbook.com/nxteu/sageuk/wso_2023123_ROW
https://europe.nxtbook.com/nxteu/sageuk/wso_2023101
https://europe.nxtbook.com/nxteu/sageuk/wso_202308
https://europe.nxtbook.com/nxteu/sageuk/wso_202307
https://europe.nxtbook.com/nxteu/sageuk/wso_202306
https://europe.nxtbook.com/nxteu/sageuk/wso_202304
https://europe.nxtbook.com/nxteu/sageuk/wso_202303
https://europe.nxtbook.com/nxteu/sageuk/wso_202302
https://europe.nxtbook.com/nxteu/sageuk/wso_202301
https://www.nxtbookmedia.com